Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
01/2003
01/09/2003WO2003002563A1 Pyrido-pyrido-pyrrolo pyrrolo-indole and pyrido-pyrrolo pyrrolo carbazole derivatives, method for the production thereof and pharmaceutical compositions containing said derivatives
01/09/2003WO2003002104A2 Use of corrinoids in the treatment of skin diseases
01/09/2003US20030009028 Separating impurities by obtaining the 5' protected 2'-deoxypurine nucleoside as inclusion crystal including a solvent such as that having a nitrile structure in order to purify the 5' protected 2'-deoxypurine nucleoside
01/09/2003US20030009027 Covalently attaching a first nucleotide or an oligonucleotide via a C-5' oxygen of the nucleotide to the substrate for producing an immobilized oligonucleotide on a substrate
01/09/2003US20030008898 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological proliferation
01/09/2003US20030008841 Anti-HCV nucleoside derivatives
01/09/2003US20030008834 Compsoitions and methods for treating epithelia and retinal tissue diseases
01/09/2003US20030008318 Determination of the number of copies of a preferential nucleotide sequence in sample; obtain sample, incubate with solid support and probe, detecting the amount of binding of the first and second labelled complementary
01/09/2003US20030008302 Sequencing of surface immobilized polymers utilizing microfluorescence detection
01/09/2003CA2452192A1 Pyrido-pyrido-pyrrolo pyrrolo-indole and pyrido-pyrrolo pyrrolo carbazole derivatives, method for the production thereof and pharmaceutical compositions containing said derivatives
01/09/2003CA2451579A1 Use of corrinoids for application in skin diseases
01/08/2003EP1272655A1 Stabilization of highly sensitive nucleic acid stains in aqueous solutions
01/08/2003EP1272501A1 Process for the preparation of phosphorothioate triesters
01/08/2003EP1272473A1 Process for preparing substituted benzimidazole compounds
01/08/2003CN1390228A Orally active A adenosine receptor agonists
01/08/2003CN1390227A Enzyme catalyzed therapeutic activation
01/07/2003US6504024 Useful as substrates for polymerase enzymes; used in preparing fluorescently-labeled nucleotides useful as substrates for thermostable polymerases
01/07/2003US6503890 Aryl phosphate derivatives of d4T having anti-HIV activity
01/07/2003CA2252813C 3- and 3,8-substituted 1,10-phenanthrolines and their use in electron and energy transfer processes
01/06/2003CA2392187A1 Combination preparation for the therapy of immunological diseases
01/03/2003WO2003000713A1 Nucleoside compounds in hcv
01/03/2003WO2003000271A2 System and method for the large scale labeling of compounds with radiohalogens
01/03/2003WO2003000200A2 β-2'-OR 3'-HALONUCLEOSIDES
01/03/2003WO2003000056A1 Joint lubrication with p2y purinergic receptor agonists
01/03/2003WO2002066020A3 Modulation of gsk-3beta activity and its different uses
01/03/2003WO2002048166A8 Indolocarbazole anticancer agents and methods of using them
01/03/2003WO2002018405A3 Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivatives
01/03/2003CA2451745A1 .beta.-2'-or 3'-halonucleosides
01/02/2003US20030004331 Method for purifying 5' -protected thymidines and novel derivatives thereof
01/02/2003US20030004330 Methods for producing nucleoside derivatives and intermediates therefor
01/02/2003US20030004325 Stability; nuclease resistance
01/02/2003US20030004322 Antiinflammatory agents; immobilized on solid support
01/02/2003US20030004122 Anticancer agents
01/02/2003US20030004119 Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
01/02/2003US20030003505 Nucleobase heterocyclic combinatorialization
01/02/2003US20030003475 Arrays for detecting nucleic acids
01/02/2003US20030003461 Truncation selex method
01/02/2003EP1270017A1 Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases
01/02/2003EP1268507A1 Antisense modulation of e2f transcription factor 1 expression
01/02/2003EP1268504A1 Nucleoside compounds and uses thereof
01/02/2003EP1268493A1 Phosphoramidate prodrugs
01/02/2003EP1267892A2 Use of cdp-choline for the treatment of alcohol withdrawal syndrome
01/02/2003EP1109785B1 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation
01/01/2003CN1097460C Amino sugar and related sugar derivatives of cytotoxic of indolopyrro locarbazoles
12/2002
12/31/2002US6500946 Low cost, simple, high yield production, including that of antiviral agent 9-(2,3-dideoxy-2-fluoro-.beta.-d-threo-pentofuranosyl)adenine (fdda)
12/31/2002US6500945 Nucleotides having chiral phosphorus linkages
12/31/2002US6500650 Method for identifying polymorphisms
12/31/2002US6500472 For enriching foods or beverages, anemia treatment
12/27/2002WO2002103008A2 Templated molecules and methods for using such molecules
12/27/2002WO2002102823A1 Stable salts of s-adenosyl-l-methionine (same) and the process for their preparation
12/27/2002WO2002102822A1 Adenosine derivative in polymorph ii form
12/27/2002WO2002102821A1 Adenosine derivative in polymorph i form
12/27/2002WO2002102820A1 Nucleoside derivatives for library preparation
12/27/2002WO2002060454A3 Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders
12/27/2002CA2451524A1 Templated molecules and methods for using such molecules
12/26/2002US20020198437 Method of manufacturing a soft hearing aid
12/26/2002US20020198224 Method for the synthesis of 2',3'-dideoxy-2',3'-didehydronucleosides
12/26/2002US20020198173 Viricides for treating HIV and hepatitis virus
12/26/2002US20020198171 Administering to a hepatitis B infection patient an effective treatment amount of a 2'fluoro- beta -D-nucleoside or salts(containing purine or pyrimidine base)
12/26/2002US20020197684 Ribozymes; for use as amplification tools in genetic engineering
12/25/2002CN1097049C Processes for preparing intermediate product used in method of diastereoselective synthesis of nucleosides
12/24/2002US6498241 2-deoxy-isoguanosines isosteric analogues and isoguanosine derivatives as well as their synthesis
12/24/2002US6498149 Culturing human placental decidua derived cells with surface markers as positive cd57 and bright hla.dr; 1-dehydroxy-2-(1-guanine, 1-uracil or 1-(7-ketopurine))ribofuranose deri-vatives; reduced side effects
12/19/2002WO2002100415A2 4'-substituted nucleosides for the treatment of diseases mediated by the hepatitis c virus
12/19/2002WO2002100354A2 Pyrrolo[2,3-d]pyrimidine nucleoside analogs
12/19/2002WO2002100152A2 Solution-phase combinatiorial library synthesis and pharmaceutically active compounds produced thereby
12/19/2002WO2002077002A3 Synthesis of selenium-derivatized nucleosides, nucleotides, phosphoramidites, triphosphates and nucleic acids
12/19/2002WO2002070533A3 Method for the synthesis of 2',3'-dideoxy-2',3'-didehydronucleosides
12/19/2002US20020193579 Non-nucleotide containing enzymatic nucleic acid
12/19/2002US20020193324 Adjusting the pH of an acidic mixture of an acid, alcohol, water and indolcarbazole glycoside compound by adding base to produce solution; heating, isolating crystals
12/19/2002US20020193314 Process for selectively producing 1-phosphorylated sugar derivative anomer and process for producing nucleoside
12/19/2002US20020192693 Apparatus for polymer synthesis
12/19/2002US20020192684 Arrays for detecting nucleic acids
12/18/2002EP1265910A2 Nucleic acids, proteins, and antibodies
12/18/2002EP1265621A2 Use of cdp-choline for the prophylactic treatment of cerebral ischemia
12/18/2002EP0715523B1 Purine nucleoside phosphorylase gene therapy for human malignancy
12/18/2002EP0135587B2 Defined sequence single strand oligonucleotides incorporating reporter groups, process for the chemical synthesis thereof, and nucleosides useful in such synthesis
12/18/2002CN1385437A Method for purifying 5'-protection Thymidine and novel derivant
12/17/2002US6495677 Nucleoside compounds
12/17/2002US6495672 Diagnosis and separation through triplex binding
12/17/2002US6495553 Methods and compositions for overcoming resistance to biologic and chemotherapy
12/17/2002US6495528 Antiinflammatory agents; inhibiting leukocyte recruitment and activation; agonists of adenosine 2a receptor
12/17/2002CA2053826C Pharmaceutical compositions active in the therapy of neurological affections in aids patients
12/12/2002WO2002099406A2 Single molecule detection systems and methods
12/12/2002WO2001054731A3 Ligand conjugates and methods for preparing same
12/12/2002US20020188116 Chemical synthesis of S-adenosyl-L-methionine with enrichment of ( S,S)-isomer
12/12/2002US20020187942 Method for producing beta-D-ribofuranose derivatives or optical isomers thereof
12/12/2002US20020187941 Pregabalin lactose conjugates
12/11/2002EP1264836A1 Processes for the preparation of indolopyrrolocarbazole derivatives
12/11/2002EP1263944A2 Nucleic acids, proteins, and antibodies
12/11/2002EP1263773A1 Oligonucleotide analogues, methods of synthesis and methods of use
12/11/2002EP1095053B1 Arylsulfone linkers for mass spectrometric analysis
12/11/2002CN1384834A Pyrrolo [2,3-d] pyrimidine nucleoside analoys
12/11/2002CN1095677C 化合物 Compound
12/10/2002US6492348 Adenosine derivatives
12/10/2002US6492347 Treatment and/or prophylaxis of infection caused by protozoan parasite by administering compound to inhibit purine nucleoside hydrolase, purine nucleoside phosphorylase, and/or purine phosphoribosyl transferase
12/10/2002US6492346 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
12/10/2002US6491871 System for determining receptor-ligand binding affinity
12/05/2002WO2002076400A3 Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease
12/05/2002US20020183502 Oligonucleotides for use in the human therapeutics and diagnostics